NASDAQ · Healthcare · Biotechnology
Faeth Therapeutics, Inc.
FTH
Faeth Therapeutics, Inc. CEO Anand Parikh · Market cap $30.7M.
$22.87
-1.80 · -7.30%
52w hi $36.7652w lo $6.33
Off 52w high 33.2%
79
STRONG
Current InsiderScore
Corp · 90d
6
6 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
6
2 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $55.00
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 23 | Brian C Stephenson | Chief Financial Officer | Buy | 1,969 | $24.84 | +$49K | 67 |
| Jun 23 | Brian C Stephenson | Chief Financial Officer | Buy | 6,836 | $24.12 | +$165K | 79 |
| Jun 22 | Anand Kiran Parikh | President and CEO | Buy | 2,806 | $19.76 | +$55K | 66 |
| Jun 22 | Brian C Stephenson | Chief Financial Officer | Buy | 1,583 | $22.40 | +$35K | 74 |
| Jun 22 | Brian C Stephenson | Chief Financial Officer | Buy | 1,797 | $20.23 | +$36K | 74 |
| Jun 22 | Brian C Stephenson | Chief Financial Officer | Buy | 3,329 | $23.28 | +$77K | 76 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun